@article{202404.1044,
	doi = {10.20944/preprints202404.1044.v1},
	url = {https://doi.org/10.20944/preprints202404.1044.v1},
	year = 2024,
	month = {April},
	publisher = {Preprints},
	author = {Alessandro Cafaro and Flavia Foca and Oriana Nanni and Marco Chiumente and Marina Coppola and Alberto Russi and Elena Svegliati and Paolo Baldo and Sabrina Orzetti and Fiorenza Enrico and Federico Foglio and Davide Pinnavaia and Vito Ladisa and Claudia Lauria Pantano and Rosa Lerose and Patrizia Nardulli and Simona Ferraiuolo and Piera Maiolino and Immacolata De Stasio and Federica Gradellini and Anna Rita Gasbarro and Rossella Santeramo and Gisella Carrucciu and Riccardo Provasi and Mario Cirino and Paola Cristina Cappelletto and Elisabetta Fonzi and Alessandra Pasqualini and Stefano Vecchia and Marianna Veraldi and Adele Emanuela De Francesco and Lucio Crinò and Angelo Delmonte and Carla Masini},
	title = {Real World Safety and Outcome of First Line Pembrolizumab Monotherapy for Metastatic NSCLC with PDL-1 Expression ≥ 50%: A National Italian Multicentric Cohort (“PEMBROREAL” Study)},
	journal = {Preprints}
}